相关实验视频
Updated: Jun 23, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
这个病人有帕金森病吗?
Goutham Rao1, Laura Fisch, Sukanya Srinivasan
1Department of Family Medicine, University of Pittsburgh, 3518 Fifth Ave, Pittsburgh, PA 15261, USA. raog@msx.upmc.edu
JAMA
|January 15, 2003
概括
准确的帕金森病 (PD) 诊断依赖于特定的临床迹象和症状. 审查震,刚性,勃拉迪基尼西亚和步态有助于区分PD,改善早期检测和治疗.
科学领域:
- 神经学 神经学
- 临床诊断 临床诊断 临床诊断
- 医学研究 医学研究
背景情况:
- 帕金森病 (PD) 诊断存在挑战,但有效的症状治疗方法可用.
- 准确的诊断对于及时和适当的患者管理至关重要.
研究的目的:
- 系统地审查有关诊断帕金森病的临床检查精度和准确性的文献.
- 为了确定PD的关键诊断症状和迹象.
主要方法:
- 在MEDLINE数据库中进行了全面的搜索,寻找1966年至2001年有关PD诊断的英语文章.
- 分析了符合纳入标准的六项研究,以确定症状和征兆的诊断准确性,尽管数据汇总因变异性而受到限制.
主要成果:
- 对各种症状和征兆计算了概率比率 (LR). 对于震 (1.3-17),刚性和勃拉迪基尼西亚组合 (4.5),失衡 (1.6-6.6),微图 (2.8-5.9),步 (3.3-15),以及在床上转身等任务中的困难 (13) 发现了高阳性LR.
- 有用的诊断标志包括 glabella 探测试 (LR,4.5) 和从脚跟到脚走路困难 (LR,2.9).
- 在所有包含的研究中都注意到了显著的选择偏差.
结论:
- 对于疑似PD病例,建议仔细评估震,刚性,勃拉迪基尼西亚,微图,步,以及功能困难 (转身,瓶子打开,站起来).
- 格拉贝拉触摸测试和脚跟到脚的行走评估是帕金森病的有价值的诊断工具.
相关概念视频
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...